Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAPA
2301
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.24M | ﹤0.01% |
68,000
+4,700
| +7% | +$91.8K |
|
|
FBRT
2302
Franklin BSP Realty Trust
FBRT
$669M
| $1.24M | ﹤0.01% |
88,333
+18,200
| +26% | +$249K |
|
2303
RE/MAX Holdings
RMAX
$263M
| $1.23M | ﹤0.01% |
44,500
+2,800
| +7% | +$82.4K |
|
|
VRAY
2304
DELISTED
ViewRay, Inc.
VRAY
| $1.23M | ﹤0.01% |
313,700
+42,500
| +16% | +$181K |
|
2305
Arrow Financial
AROW
$725M
| $1.23M | ﹤0.01% |
40,227
+2,864
| +8% | +$93.8K |
|
|
FFAI
2306
Faraday Future Intelligent Electric
FFAI
$9.79M
| – | – |
0
| – | – |
|
|
TVRD
2307
Tvardi Therapeutics
TVRD
$22.1M
| $1.23M | ﹤0.01% |
2,808
+364
| +15% | +$149K |
|
|
BTRS
2308
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $1.22M | ﹤0.01% |
163,200
+11,800
| +8% | +$76.4K |
|
|
TTCF
2309
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $1.22M | ﹤0.01% |
96,900
+7,300
| +8% | +$92.4K |
|
|
OLP
2310
One Liberty Properties
OLP
$523M
| $1.22M | ﹤0.01% |
39,552
+3,300
| +9% | +$102K |
|
|
QUOT
2311
DELISTED
Quotient Technology Inc
QUOT
| $1.21M | ﹤0.01% |
189,800
+13,800
| +8% | +$92.5K |
|
2312
Rigel Pharmaceuticals
RIGL
$782M
| $1.21M | ﹤0.01% |
40,438
+3,190
| +9% | +$86.4K |
|
2313
Vaxcyte
PCVX
$8.88B
| $1.21M | ﹤0.01% |
50,000
+4,100
| +9% | +$89.6K |
|
2314
The Joint Corp
JYNT
$123M
| $1.21M | ﹤0.01% |
34,100
+2,700
| +9% | +$125K |
|
2315
Hingham Institution for Saving
HIFS
$689M
| $1.2M | ﹤0.01% |
3,500
+200
| +6% | +$73.8K |
|
|
BNT
2316
Brookfield Wealth Solutions
BNT
$12.2B
| $1.2M | ﹤0.01% |
31,500
+1,650
| +6% | +$62.2K |
|
|
ROVR
2317
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.2M | ﹤0.01% |
207,500
+34,600
| +20% | +$207K |
|
|
AGEN
2318
Agenus
AGEN
$311M
| $1.2M | ﹤0.01% |
24,752
+3,847
| +18% | +$208K |
|
2319
Pennant Group
PNTG
$1.34B
| $1.19M | ﹤0.01% |
64,000
+4,800
| +8% | +$80.1K |
|
2320
HealthStream
HSTM
$829M
| $1.19M | ﹤0.01% |
59,700
+3,800
| +7% | +$85.9K |
|
|
NWLI
2321
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.19M | ﹤0.01% |
5,649
+300
| +6% | +$64K |
|
2322
Pulmonx
LUNG
$98.4M
| $1.19M | ﹤0.01% |
47,900
+3,900
| +9% | +$101K |
|
|
KE
2323
Kimball Electronics
KE
$606M
| $1.19M | ﹤0.01% |
59,400
+4,400
| +8% | +$85.3K |
|
|
IDEX
2324
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $1.19M | ﹤0.01% |
8,473
+883
| +12% | +$113K |
|
2325
Karyopharm Therapeutics
KPTI
$46M
| $1.19M | ﹤0.01% |
10,717
+754
| +8% | +$94K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.